Pancreatic Cancer Research

ResearcherWuhan Union HospitalActive in the last 2 years

Hongkun Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9901-3068; OpenAlex author ID A5089539092. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 paper

Papers 3

  1. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis. Co-author DOI 10.1016/j.bbadis.2024.167183↗
  2. ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation. First author DOI 10.1007/s13402-022-00731-3↗
  3. CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression. Co-author DOI 10.7150/ijbs.68995↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Sun · 3 shared papers, 2022–2024 · strength 0.51
  2. Heshui Wu · 3 shared papers, 2022–2024 · strength 0.51
  3. Dianyun Ren · 2 shared papers, 2022–2024 · strength 0.36
  4. Yingke Zhou · 2 shared papers, 2022–2024 · strength 0.33
  5. Junpeng Meng · 1 shared paper, 2022 · strength 0.19
  6. Yuhan Zhao · 1 shared paper, 2024 · strength 0.18
  7. Gengdu Qin · 1 shared paper, 2024 · strength 0.18
  8. Jingyuan Zhao · 1 shared paper, 2024 · strength 0.18
  9. Huan Zhang · 1 shared paper, 2022 · strength 0.15
  10. Feng Guo · 1 shared paper, 2022 · strength 0.15
  11. Xin Jin · 1 shared paper, 2022 · strength 0.15
  12. Haixin Yu · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.